Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Hackett Group | HCKT | Oct 31, 2024 | 24.32 | -1.02 |
The Hain Celestial Group | HAIN | Oct 31, 2024 | 8.73 | -0.23 |
The Hershey | HSY | Oct 31, 2024 | 177.58 | +0.05 |
The Herzfeld Caribbean Basin Fund | CUBA | Oct 31, 2024 | 2.41 | -0.82 |
The Honest Company | HNST | Oct 31, 2024 | 3.72 | -4.62 |
The Intergroup | INTG | Oct 31, 2024 | 14.38 | +0.63 |
The J.M Smucker Company | SJM | Oct 31, 2024 | 113.51 | -0.36 |
The Joint | JYNT | Oct 31, 2024 | 11.05 | -1.34 |
The Marygold Companies | MGLD | Oct 31, 2024 | 1.28 | 0.00 |
The ODP | ODP | Oct 31, 2024 | 31.03 | -0.16 |
The OLB Group | OLB | Oct 31, 2024 | 1.94 | -12.61 |
The Oncology Institute | TOI | Oct 31, 2024 | 0.31 | -1.59 |
The ONE Group Hospitality | STKS | Oct 31, 2024 | 3.42 | -2.56 |
The Pennant Group | PNTG | Oct 31, 2024 | 31.97 | -3.97 |
The Real Brokerage | REAX | Oct 31, 2024 | 5.46 | -3.19 |
The Real Estate Select Sector SPDR Fund | XLRE | Oct 31, 2024 | 43.20 | -1.75 |
The RealReal | REAL | Oct 31, 2024 | 2.90 | -4.61 |
The RMR Group A | RMR | Oct 31, 2024 | 24.07 | -0.54 |
The Shyft Group | SHYF | Oct 31, 2024 | 12.92 | -2.20 |
The Trade Desk A | TTD | Oct 31, 2024 | 120.21 | -1.45 |
The9 ADR | NCTY | Oct 31, 2024 | 8.29 | -5.69 |
TherapeuticsMD | TXMD | Oct 31, 2024 | 1.55 | 0.00 |
Theratechnologies | THTX | Oct 31, 2024 | 1.21 | -3.20 |
Theravance Biopharma | TBPH | Oct 31, 2024 | 8.24 | -2.72 |
Theriva Biologics | TOVX | Oct 31, 2024 | 1.46 | -1.35 |
Thermo Fisher Scientific | TMO | Oct 31, 2024 | 546.32 | -0.78 |
Thermon Group | THR | Oct 31, 2024 | 26.21 | -1.50 |
Third Coast Bancshares | TCBX | Oct 31, 2024 | 32.57 | -1.45 |
Third Harmonic | THRD | Oct 31, 2024 | 13.79 | -2.82 |
Thomson Reuters | TRI | Oct 31, 2024 | 163.64 | -1.74 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.